Chuan Lin
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (3 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers)Renal cell carcinoma treatment (2 papers)
- Cited by
- HepatologyCancer ResearchImmunology
- Journals
- PLoS ONEHepatologyNutrients
- Partner nations
- ChinaSouth KoreaUnited States
In The Last Decade
Chuan Lin
17 papers receiving 589 citations
Peers
Comparison fields: 5 of 75
- Molecular Biology 207
- Oncology 190
- Hepatology 190
- Immunology 160
- Cancer Research 132
Countries citing papers authored by Chuan Lin
This map shows the geographic impact of Chuan Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chuan Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chuan Lin more than expected).
Fields of papers citing papers by Chuan Lin
This network shows the impact of papers produced by Chuan Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chuan Lin. The network helps show where Chuan Lin may publish in the future.
Co-authorship network of co-authors of Chuan Lin
This figure shows the co-authorship network connecting the top 25 collaborators of Chuan Lin. A scholar is included among the top collaborators of Chuan Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chuan Lin. Chuan Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 0 | |
| 6 | 50 | |
| 7 | 19 | |
| 8 | 49 | |
| 9 | Cardiac allograft tolerance induced by isogeneic CD4+CD25+ regulatory T cells. | 1 |
| 10 | 31 | |
| 11 | 65 | |
| 12 | 37 | |
| 13 | 32 | |
| 14 | 191 | |
| 15 | 42 | |
| 16 | 69 | |
| 17 | 1 | |
| 18 | [Genotoxicity comparison between gasoline- and methanol-fueled exhaust by TK gene mutation assay]. | 2 |
| 19 | 2 | |
| 20 | [Surgical treatment of hepatocellular carcinoma with tumor thrombus in the inferior vena cava]. | 2 |
About Chuan Lin
Chuan Lin is a scholar working on Health Informatics, Hepatology and Biological Psychiatry, having authored 20 papers that have together received 596 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and Renal cell carcinoma treatment (2 papers). The work is most often cited by research in Hepatology (190 citations), Cancer Research (132 citations) and Immunology (160 citations). Chuan Lin has collaborated with scholars based in China, South Korea and United States. Frequent co-authors include Yuan Yang, Ze‐Ya Pan, Weiping Zhou, Mengchao Wu, Yanmei Han, Zhengping Jiang, Zhubo Chen, Xuetao Cao, Tian Yang and Weiping Zhou. Their work appears in journals such as PLoS ONE, Hepatology and Nutrients.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.